UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):March 11, 2004
| |
| Lifecore Biomedical, Inc. |
|
| (Exact name of Registrant as specified in its charter) |
| | | | | |
| Minnesota | | O-4136 | | 41-0948334 |
| |
| |
|
(State or other jurisdiction of
incorporation or organization) | | (Commission File Number) | | (IRS Employer Identification No.) |
| | | | | |
3515 Lyman Boulevard
Chaska, Minnesota | | | | 55318 | |
| | | |
| |
| (Address of principal executive offices) | | | | (Zip Code) |
Registrant’s telephone number, including area code: 952-368-4300
TABLE OF CONTENTS
Item 7. Financial Statements and Exhibits
(c) The following exhibit is being furnished herewith:
| |
| | 99.1 Press release dated March 11, 2004 |
Item 9. Regulation FD Disclosure
On March 11, 2004 Lifecore Biomedical, Inc. (“Lifecore”) issued a press release which announced today that Larry Hiebert has been appointed Vice President of Operations and David Noel has been appointed Vice President of Finance and Chief Financial Officer.
A copy of Lifecore’s press release is attached hereto as Exhibit (99.1) and hereby incorporated by reference.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | |
| | | | | LIFECORE BIOMEDICAL, INC. |
| |
| Dated: | | March 11, 2004 | | /w/ Dennis J. Allingham
Dennis J. Allingham
Chief Executive Officer and President |
Exhibit Index
| | | |
| 99.1 | | Press release dated March 11, 2004 |
